Google+

Saving limbs. And lives.

When a tourniquet is needed in an emergency situation, only one result matters—how fast it can stop the bleeding. And only one tourniquet’s performance in that critical outcome has been ranked first in recent U.S. military studies.

(Currently unavailable in your country. Please contact Pyng for more information.)


The MAT® Tourniquet from Pyng is a versatile and efficient tourniquet, providing fast application, simple and effective one-handed operation.  Stops blood loss with complete occlusion in about 30 seconds. Designed to be self-administered by individual military personnel or civilians—as well as used by medical personnel—it is the only tourniquet that meets all U.S. Department of Defense performance requirements.

MAT® provides consistent superior occlusion efficacy, speed of application, ease of use, and modulated constriction, which saves lives and limbs. And in three independent studies by the Army, Navy, and Marine Corps that compared tourniquet products and methodologies, MAT® performance was ranked first for stopping blood flow, the primary clinical outcome a tourniquet is supposed to deliver.

Initially developed for the U.S. Department of Defense, MAT® has been adopted by emergency first responders and law-enforcement agencies around the world. MAT® won the IDSA’s Gold Award for Best Medical Product Design of 2006 and in 2007 was a finalist for the highly prestigious INDEX Award for best medical product in the world.

MAT® Advantages

  • Saving trapped limbs: Completely adjustable to fit on any trapped limb to safely provide arterial occlusion
  • Simple application: Quick, one-handed application—ratchet system prevents tourniquet from slipping backward and loosen hold
  • Rapid release: Designed for rapid release and reapplication on the same patient; routinely applied start to finish in 10 seconds or less
  • Effective and trusted: The ability to quickly and efficiently stop bleeding has returned the tourniquet to prominence within the emergency medical tool kit; its effectiveness is once again recognized by the medical community